URUS Group
Gregg Topoleski has a diverse work experience in finance and business development. Gregg'smost recent position is as a Chief Financial Officer at URUS Group, starting in May 2022. Prior to that, they held various roles at Exact Sciences from 2020 to 2022, including Head of Finance for the Screening Business Unit and Head of Finance for the Pipeline. In 2020, they worked as a Business Development Advisor at Olifant Medical. Before that, they spent several years at Acelity, where they held positions such as VP of Finance for Global Operations and Innovation, Integration Leader for Crawford Medical, and Vice President of Finance for AWT Franchises. Prior to Acelity, they worked at GE Healthcare and GE in roles such as CFO for Anesthesia & Respiratory Care, Business Development, and various finance management positions. Gregg's experience spans across different industries and includes not only finance but also business development and integration leadership.
Gregg Topoleski holds a Bachelor of Science degree in Finance from The Ohio State University Fisher College of Business. The specific start and end dates of their education are not provided.
URUS Group
URUS was established to meet the needs of dairy and beef cattle producers around the globe today and far into the future. As a holding company with cooperative and private ownership, URUS connects well-established agricultural organizations – Alta Genetics, GENEX, Jetstream Genetics, PEAK, SCCL and VAS. Each of these organizations has its own unique identity, products and services. These companies provide cutting-edge genetics to accelerate genetic progress, customized reproductive service to maximize conceptions, dairy management information to take producers to the frontline of smart dairy farming, and an array of products and services to help the cow achieve her genetic potential. Put simply, these companies focus on the cow and her caretaker. Yet, URUS is more than the sum of its parts. The URUS framework facilitates synergies between its companies – synergies that will drive new developments. The size and scale of URUS also contributes to significant investment in research and technology. URUS will build the tools, products and genetics that cow caretakers will need for the sustainable, productive and profitable herds of tomorrow. Count on URUS – and its companies – to be in it for the long term. Count on URUS to invest in the products and services that will enhance producers’ abilities to be successful in effectively and efficiently feeding the world.